Subcutaneous bolus administration of cytosine arabinoside (Ara-C) has been used as an alternative to continuous intravenous infusion. However, the pharmacokinetics of subcutaneous bolus Ara-C have not been satisfactorily documented in man. The plasma concentrations of Ara-C were therefore compared f
Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs
β Scribed by J. Catharine R. Scott-Moncrieff; Thomas C. K. Chan; Myra L. Samuels; James R. Cook; Gordon L. Coppoc; Dennis B. DeNicola; Ralph C. Richardson
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 658 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Concentrations of araβCTP in leukemic cells isolated from CSF and of araβC in lumbar CSF were measured following intraventricular araβC administration in two girls with refractory meningeal leukemia. CSF samples were collected with a permanent intrathecalβlumbar catheter. In contrast to
## Abstract The aim of this study was to investigate the pharmacokinetic behavior of huperzine A (Hup A) in plasma and cerebrospinal fluid (CSF) after intranasal administration (0.5βmg/kg) in male SpragueβDawley rats. A pharmacokinetic study of intravenous Hup A (0.5βmg/kg) was also performed. The